Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-10-10

FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved Lannett Company's supplemental application for fluoxetine hydrochloride, a generic version of fluoxetine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine hydrochloride (Fluoxetine hydrochloride)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE HYDROCHLORIDE)